Reduced Epidermal p21 Expression Is Identified in Some Subjects on Systemic GLP-1 Receptor Agonists: A Hypothesis-Generating Pilot Study of Metabolic Modulation in Human Skin Senescence.

Saranya Wyles, Shilpa Gopinath, Brock Lynn, Zachary Pfizenmaier, Bengisu Ozarslan, K-Raman Purushothaman

Department of Dermatology, Mayo Clinic, Rochester, Minnesota.Department of Dermatology, Mayo Clinic, Rochester, Minnesota. · pubmed

Paper

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) exert systemic metabolic and anti-inflammatory effects that may be relevant to cellular senescence, a key driver of skin aging. However, human cutaneous data are lacking.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper suggests that reduced epidermal p21 expression may be linked to the effects of systemic GLP-1 receptor agonists on skin senescence. This study is relevant as it explores potential metabolic modulation in human skin aging, addressing a root cause of aging rather than merely treating symptoms.

Author of this paper? Send a correction.